Resource Library
Advanced CLD with S-CHOice®: higher productivity with transposase technology and improved ADCC with S-AfuCHO™
Are you looking to strengthen your cell line development (CLD) strategy? At Samsung Biologics, we’re continuously innovating to enhance existing platforms and meet diverse biomanufacturing needs. Advance your CLD with transposase technology and FUT8 knockout engineering integrated into our S-CHOice® platform.
With resulting superior ADCC activity, antibodies generated from this S-AfuCHO™ line are more potent and show lower levels of fucosylation. Paired with higher purity and product yield enabled by transposase systems, this dual technology helps speed up timelines while maintaining high quality.
Check out our latest poster to learn more!
Are you looking to strengthen your cell line development (CLD) strategy? At Samsung Biologics, we’re continuously innovating to enhance existing platforms and meet diverse biomanufacturing needs. Advance your CLD with transposase technology and FUT8 knockout engineering integrated into our S-CHOice® platform.
With resulting superior ADCC activity, antibodies generated from this S-AfuCHO™ line are more potent and show lower levels of fucosylation. Paired with higher purity and product yield enabled by transposase systems, this dual technology helps speed up timelines while maintaining high quality.
Check out our latest poster to learn more!